SCHEMBL28754643

SCHEMBL28754643

N#Cc1ccc(CCC(=O)c2c[c]ccc2O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
FFAR1 O14842 5/20 0.41
HTT P42858 1/20 0.40
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
SLC5A1 P13866 3/20 0.38
SLC5A2 P31639 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
SLC16A3 O15427 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TTR P02766 1/20 0.38
ESR1 P03372 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27636901 0.87 CTBP2 (0.43) HTTMEN1KMT2AMAPTKDM4E
SCHEMBL27617796 0.84 FFAR1 (0.45) CYP19A1FFAR1SLC5A1SLC5A2MAPT
SCHEMBL27617799 0.82 CYP19A1 (0.49) CYP19A1SLC5A1SLC5A2MEN1KMT2A
SCHEMBL27617791 0.82 CYP19A1 (0.55) CYP19A1FFAR1HTTSLC5A1SLC5A2
SCHEMBL28757643 0.79 CYP19A1 (0.45) CYP19A1FFAR1HTTSLC5A1SLC5A2
SCHEMBL27617814 0.75 NPC1 (0.53) CYP19A1HTTSLC5A1SLC5A2MAPT
SCHEMBL27636907 0.75 TSHR (0.39) CYP19A1FFAR1KDM4EALDH1A1LMNA
SCHEMBL10671478 0.75 GSK3B (0.59) FFAR1HTTMMP12MMP13GSK3B
SCHEMBL6761458 0.73 HPGD (0.50) CYP19A1HTTMEN1KMT2AMAPT
SCHEMBL7338789 0.72 FFAR1 (0.53) FFAR1HTTMMP12MMP13TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1717409-A Pyrazolonaphthyridine derivative GRELAN PHARMACEUTICAL CO (JP) 2006-01-04 CN disclosed